July 30 (Reuters) - Medical device maker Dexcom raised its full-year revenue forecast and beat quarterly estimates on ...

DexCom's (DXCM) upcoming national coverage determination for its continuous glucose monitoring system and strong demand momentum could support an even more positive H2 outlook, RBC Capital Markets ...

FTC cases reveal major health apps disclosed blood pressure and glucose data to advertising and analytics companies without ...

Insulet (PODD) stock drops as the company cuts 2026 revenue guidance; Other diabetes plays Tandem Diabetes (TNDM) and Dexcom ...

Diabetes technology introduced new challenges beyond glycaemic control, highlighting opportunity for patient centred device ...

DexCom’s second quarter was marked by robust revenue growth and a significant margin expansion, with management attributing ...

It is no longer possible to ask the FDA to keep pace with software development by doing the same reviews faster,” writes Dana ...

WESTBOROUGH, Mass., August 06, 2026--eClinicalWorks®, one of the largest ambulatory cloud EHRs, announced that Diabetes and Metabolism Specialists has achieved significant operational and clinical ...

The ring contains the entire sensing system rather than relying on a separate patch or external reader. One section houses the sweat collection system, fluid channel, and sensors, while another ...

(NASDAQ: GCTK) ("Glucotrack" or the "Company") today announced definitive agreements for approximately $5.5 million in financing from participating institutional investors, including a $2.0 million ...

We've ranked the world's largest diabetes technology companies — and there's plenty more as we explore the latest in this ...

Abbott Laboratories (NYSE:ABT) currently trades at $105.70, while the Street’s consensus price target sits at $118.42, ...